Eisen-Suppressed-Inventions-and-other-Discoveries-True-Stories-of ...

The Suppression of Alternative Medical Therapies 109
AMA, ACS and the U.S. Department of Health, Education and Welfare
(now Health and Human Services or HHS) were deliberately falsifying
information, literally lying, committing unconstitutional acts and in other
ways thwarting potential cancer cures to which they were opposed.
Dr. Burk's famous May 30, 1972 letter to Congressman Louis Frey, Jr.
dealt with the issue of why the FDA had revoked an Investigative New
Drug (IND) application. The IND application, according to Dr. Burk, was
superior to many routinely approved. But it involved testing laetrile, a
controversial, nonpatentable product opposed by the California Medical
Association (CMA). FDA approved the original application, then rescinded
the license, apparently because of pressure from the surgeon general, a
member of the CMA and a laetrile foe.
Dr. Burk was not an advocate of laetrile. He was, however, in favor of
fair testing. He was totally opposed to what he bluntly called "misleading
and indeed fraudulent" FDA reports. In his correspondence with Congress,
he openly referred to "FDA corruption."
Corruption indeed. It takes several forms. Refusing to allow investigation
of a non-toxic compound which might help cancer patients is one.
Failing to assert itself when a drug tested on human beings was determined
to cause cancer is another. Here are the facts of such a case:
In August 1969 it was learned that a drug called Cinanserin, produced by
E. R. Squibb and Sons, Princeton, New Jersey, caused tumors in the livers of
rats. Human testing of the drug was thus stopped. But Squibb's executives
did not want to do follow-ups on the humans who had taken Cinanserim.
For three years, the FDA tried to persuade Squibb to do follow-up studies.
(Compare this approach with what the FDA does to alternative cancer
treatments which actually work—raids, confiscation of documents, jail,
etc. With the large drug companies, FDA tries persuasion!)
Finally, in 1972, the FDA and the National Academy of Sciences set up
a committee to examine procedures on follow-ups when a drug was found
to be dangerous. Who was appointed to head the committee The vice-president
of Squibb whom the FDA had tried for three years to persuade to do
follow-ups on those people who had been given the cancer-causing drug!
The FDA has a long history of ignoring dangerous drugs and chemical
additives marketed by the big drug companies while using bureaucratic
delays, legal harassment, unconstitutional procedures, and even falsified
evidence to stop unorthodox cancer treatments. In 1964, the FDA initiated
a multimillion dollar prosecution of Andrew Ivy, vice-president and
professor of physiology at the University of Illinois. Ivy was former chairman
of the National Cancer Institute's National Advisory Council on
Cancer. He was an internationally recognized scholar and a prolific author
of scientific papers.